Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access

NACompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

July 8, 2022

Primary Completion Date

May 9, 2023

Study Completion Date

May 11, 2023

Conditions
Heart DiseasesAtrial Fibrillation
Interventions
DEVICE

AThrough radiofrequency transseptal puncture system

Utilizing AThrough radiofrequency transseptal puncture system for left atrial access

DEVICE

Traditional mechanical transseptal puncture needle

Utilizing Traditional mechanical transseptal puncture needle for left atrial access

Trial Locations (4)

210000

The First Affiliated Hospital with Nanjing Medical University, Nanjing

315000

The First Affiliated Hospital of Ningbo University, Ningbo

450000

The 7th People's Hospital of Zhengzhou, Zhengzhou

Unknown

Tianjin Chest Hospital, Tianjin

All Listed Sponsors
lead

Hangzhou NOYA MedTech Co. Ltm.

INDUSTRY

NCT06386458 - Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access | Biotech Hunter | Biotech Hunter